Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study

被引:44
|
作者
Rice, Megan S. [1 ,2 ,3 ]
Murphy, Megan A. [1 ,2 ,3 ]
Vitonis, Allison F. [3 ,4 ]
Cramer, Daniel W. [1 ,3 ,4 ]
Titus, Linda J. [5 ,6 ]
Tworoger, Shelley S. [1 ,2 ,3 ]
Terry, Kathryn L. [1 ,3 ,4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Brigham & Womens Hosp, Dept Obstet & Gynecol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA
[5] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA
[6] Geisel Sch Med Dartmouth, Dept Pediat, Hanover, NH USA
关键词
tubal ligation; tubal sterilization; hysterectomy; epithelial ovarian cancer; REPRODUCTIVE RISK-FACTORS; UNITED-STATES; WHITE WOMEN; STERILIZATION; BRCA1; OOPHORECTOMY; MUTATIONS; CARRIERS; METAANALYSIS; HISTORY;
D O I
10.1002/ijc.28249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have observed that tubal ligation and hysterectomy are associated with a decreased risk of ovarian cancer; however, little is known about whether these associations vary by surgical characteristics, individual characteristics or tumor histology. We used logistic regression to examine tubal ligation, simple hysterectomy and hysterectomy with unilateral oophorectomy in relation to risk of epithelial ovarian cancer in the New England Case-Control Study. Our primary analysis included 2,265 cases and 2,333 controls. Overall, tubal ligation was associated with a lower risk of epithelial ovarian cancer [odds ratio (OR)=0.82, 95% confidence interval (CI): 0.68-0.97], especially for endometrioid tumors (OR=0.45, 95% CI: 0.29-0.69). The inverse association between tubal ligation and ovarian cancer risk was stronger for women who had undergone the procedure at the time of last delivery (OR=0.60, 95% CI: 0.42-0.84) rather than at a later time (OR=0.93, 95% CI: 0.75-1.15). Overall, simple hysterectomy was not associated with ovarian cancer risk (OR: 1.09, 95% CI: 0.83-1.42), although it was associated with a nonsignificant decreased risk of ovarian cancer among women who underwent the procedure at age 45 or older (RR: 0.64, 95% CI: 0.40-1.02) or within the last 10 years (OR=0.65, 95% CI: 0.38-1.13). Overall, women who had a hysterectomy with a unilateral oophorectomy had significantly lower risk of ovarian cancer (OR=0.65, 95% CI: 0.45-0.94). In summary, tubal ligation and hysterectomy with unilateral oophorectomy were inversely associated with ovarian cancer risk in a large population-based case-control study. Additional research is necessary to understand the potential biologic mechanisms by which these procedures may reduce ovarian cancer risk. What's new? Tubal ligation and hysterectomy are generally known to lower ovarian cancer risk. However, little is known whether this risk reduction is influenced by the details of the surgical procedures or by the tumor histology. In this large case-control study, the authors show that tubal ligation was associated with a 18% reduced risk in ovarian cancer with strongest effects in endometrioid tumors and among women who underwent the procedure after the last childbirth. No overall association with simple hysterectomy was observed but hysterectomy with unilateral oophorectomy lowered the risk by 35%, underscoring the benefit of the procedure in the prevention of ovarian cancer.
引用
收藏
页码:2415 / 2421
页数:7
相关论文
共 50 条
  • [41] Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study
    Riman, T
    Dickman, PW
    Nilsson, S
    Correia, N
    Nordlinder, H
    Magnusson, CM
    Persson, IR
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (04) : 363 - 373
  • [42] Micronutrients and ovarian cancer: A case-control study in Italy
    Bidoli, E
    La Vecchia, C
    Talamini, R
    Negri, E
    Parpinel, M
    Conti, E
    Montella, M
    Carbone, A
    Franceschi, S
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (11) : 1589 - 1593
  • [43] A case-control study of diet and the risk of ovarian cancer
    Pan, SY
    Ugnat, AM
    Mao, Y
    Wen, SW
    Johnson, KC
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (09) : 1521 - 1527
  • [44] Differences in risk factors for epithelial ovarian cancer by histologic type - Results of a case-control study
    Risch, HA
    Marrett, LD
    Jain, M
    Howe, GR
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (04) : 363 - 372
  • [45] NEOADJUVANT CHEMOTHERAPY IN EPITHELIAL OVARIAN CANCER: A CASE-CONTROL STUDY IN A LEBANESE TERTIARY CARE CENTER
    Atallah, D.
    Moubarak, M.
    Dagher, B.
    Khalil, N.
    El Kassis, N.
    Rawadi, E.
    Chahine, G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A40 - A40
  • [46] Dietary Inflammatory Index and Epithelial Ovarian Cancer in Southern Chinese Women: A Case-Control Study
    Tang, Li
    Ngoc Minh Pham
    Lee, Andy H.
    Shivappa, Nitin
    Hebert, James R.
    Zhao, Jian
    Su, Dada
    Binns, Colin W.
    Li, Chunrong
    [J]. CANCER CONTROL, 2020, 27 (01)
  • [47] Intraperitoneal (IP) chemotherapy (CT) in epithelial ovarian cancer (EOC): A matched case-control study
    Kotecki, N.
    Tresch, E.
    Cousin, S.
    Chevalier, A.
    Vanlerenberghe, E.
    Bresson, L.
    Narducci, F.
    Leblanc, E.
    Lesoin, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S549 - S549
  • [48] REPRODUCTIVE AND OTHER FACTORS AND RISK OF EPITHELIAL OVARIAN-CANCER - AN AUSTRALIAN CASE-CONTROL STUDY
    PURDIE, D
    GREEN, A
    BAIN, C
    SISKIND, V
    WARD, B
    HACKER, N
    QUINN, M
    WRIGHT, G
    RUSSELL, P
    SUSIL, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (06) : 678 - 684
  • [49] Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer - a nationwide case-control study
    Baandrup, Louise
    [J]. DANISH MEDICAL JOURNAL, 2015, 62 (07):
  • [50] Aspirin and ovarian cancer: An Italian case-control study
    Tavani, A
    Gallus, S
    La Vecchia, C
    Conti, E
    Montella, M
    Franceschi, S
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (09) : 1171 - 1173